Related Experiment Video
Updated: May 11, 2026

Early Weight-Bearing Rehabilitation Protocol After Anterior Cruciate Ligament Reconstruction
Published on: March 1, 2024
Late group-based rehabilitation has no advantages compared with supervised home-exercises after total knee
Majbritt Madsen1, Kristian Larsen, Inger Kirkegård Madsen
1Orthopaedic Research Unit, Department of Orthopaedics, Holstebro Regional Hospital, Lægårdvej 12, Holstebro, Denmark.
Introduction:
This study aimed to test whether group-based rehabilitation focusing on strength training, education and self-management is more effective than individual, supervised home-training after fast-track total knee arthroplasty (TKA).
Material And Methods:
We allocated 80 participants undergoing primary TKA to either group-based rehabilitation or individual, supervised home-training (40 participants in each group). The group-based rehabilitation consisted of 12 outpatient visits during six weeks including strength and endurance exercises, education and self-management combined with home exercises. The primary outcome was Oxford Knee Score; secondary outcomes were EuroQoL-5 Dimensions QoL and Physical Function of the Medical Outcomes Short Form 36. Tertiary outcomes were pain, knee range of motion, tandem test, Leg Extensor Power, 10-m walking test, 30-sec. and five-times sit-to-stand. Outcomes were assessed four weeks, three months and six months after surgery. In addition, the questionnaires were completed before surgery.
Results:
We found no difference in gain of function or quality of life between the two groups at three and six months follow-up.
Conclusion:
Individual, supervised home-training and group-based rehabilitation programmes improved patients' quality of life and physical function equally six months after TKA.
Funding:
This study was funded by Holstebro Municipality, Region of Central Jutland, and Lundbeck Centre for Fast-Track Hip and Knee Surgery.
Trial Registration:
The study was registered in the Danish Data Protection Agency (Registration no.: 1-16-02-41-10) and Clinical Trials (Registration no.: KL24621).